Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for vitamin root_Display\ Name in Display Name (approximate match)

Showing 2241 - 2250 of 2492 results

First page
Previous page
Next page
Next page

Influenza A Virus A/West Virginia/30/2022 (H1N1) recombinant hemagglutinin antigen

MGF6W7RFC8

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c3cd915-babe-49c0-8aac-bf0247a17f3e

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c3cd915-babe-49c0-8aac-bf0247a17f3e

Class:

CONCEPT

INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

GB6ADZ2ASN

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

2I1EOL437M

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc8b76d7-97c4-4d1f-b96a-5cdb86edf40f

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc8b76d7-97c4-4d1f-b96a-5cdb86edf40f

Class:

CONCEPT

INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

DC4ELG1BFZ

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

I282A48KKK

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

69H0YJ871T

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

Class:

CONCEPT

INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

D2053D6YQU

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a6acc7-47a5-4515-91a1-e291264ccaf0

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1a6acc7-47a5-4515-91a1-e291264ccaf0

Class:

CONCEPT

INFLUENZA A VIRUS A/TEXAS/50/2012 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

1IQZ1WCE3Y

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb2aad7e-82d2-47c0-9eb3-08ac62641a47

Class:

CONCEPT

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

1SE9Z7D2QR

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

Class:

CONCEPT

INFLUENZA A VIRUS A/VICTORIA/361/2011 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

K5313H4VGS

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8aa934c-d74e-4c7c-b2fc-d3b8b46f4529

Class:

CONCEPT

Concept

Influenza A Virus A/West Virginia/30/2022 (H1N1) recombinant hemagglutinin antigen

Concept

INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/SWITZERLAND/9715293/2013 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/TEXAS/50/2012 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/CALIFORNIA/7/2009 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/VICTORIA/361/2011 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Showing 2241 - 2250 of 2492 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1